Pediatr. praxi. 2012;13(3):182-184

Complicated pneumonia in a 16 years old boy

MUDr.Jiří Fremuth, Ph.D.1, doc.MUDr.Jiří Kobr, Ph.D.1, MUDr.Renata Vondráková2, MUDr.Lucie ©perlová3, MUDr.Vladimír ©pidlen4, MUDr.Kateřina Pizingerová, Ph.D.1, MUDr.Lumír ©aąek1, MUDr.Marcela Kreslová1, MUDr.Jana Zamboryová1
1 Dětská klinika, LF UK a FN Plzeň
2 Radiodiagnostická klinika, LF UK a FN Plzeň
3 Dětské oddělení, Domaľlice
4 Chirurgická klinika, LF UK a FN Plzeň

The authors present a case of 16 years old boy, who was conservatively treated for right sided necrotising pneumonia and pleural empyema.

Keywords: necrotising, pneumonia, empyema, fibrinolysis

Published: June 18, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fremuth J, Kobr J, Vondráková R, ©perlová L, ©pidlen V, Pizingerová K, et al.. Complicated pneumonia in a 16 years old boy. Pediatr. praxi. 2012;13(3):182-184.
Download citation

References

  1. Mani CS, Murray DL. Acute pneumonia and its complications. In: Long S, Pickering LK, Prober CG, et al. Principles and practice of pediatric infectious diseases, Saunders, 3rd Edition, 2008, Kapitola 36. Go to original source...
  2. http://emedicine.medscape.com/article/967822-treatment.
  3. Donowitz GR. Acute pneumonia. In: Mandell GL, Bennett JE, Dolin R, et al. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, Churchill Livingstone, 7th Edition, 2009, Kapitola 64. Go to original source...
  4. Byington CL, Korgenski K, Daly J, et al. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006; 25(3): 250-254. Go to original source... Go to PubMed...
  5. Li ST, Tancredi DJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics. 2010; 125(1): 26-33. Go to original source... Go to PubMed...
  6. Pletz MW, Welte T, Klugman KP. The paradox in pneumococcal serotypes: highly invasive does not mean highly lethal. Eur Respir J. 2010; 36(4): 712-713. Go to original source... Go to PubMed...
  7. Balfour-Lynn IM, Abrahamson E, Cohen G, et al. BTS guidelines for the management of pleural infection in children. Thorax. 2005; 60 (Suppl 1): i1-21. Go to original source... Go to PubMed...
  8. Smyth AR, Barbato A, Beydon N, et al. Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J. 2010; 35(2): 247-265. Go to original source... Go to PubMed...
  9. Cameron R, Davies HR. Intrapleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev, 2008; 16;(2): CD002312. Go to original source... Go to PubMed...
  10. Kobr J, Pizingerova K, Sasek L, et al. Treatment of encapsulated pleural effusions in children: a prospective trial. Pediatrics international 2010; 52(3): 453-458. Go to original source... Go to PubMed...
  11. Thomson AH, Hull J, Kumar MR, et al. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002; 57(4): 343-347. Go to original source... Go to PubMed...
  12. Bouros D, Schiza S, Patsourakis G, et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med. 1997; 155(1): 291-295. Go to original source... Go to PubMed...
  13. Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 2004; 59(6): 522-525. Go to original source... Go to PubMed...
  14. Heffner JE, Klein JS, Hampson C. Interventional management of pleural infections. Chest 2009; 136(4): 1148-1159. Go to original source... Go to PubMed...
  15. Bébrová E, Beneą J, Číľek J, et al. Doporučený postup pro antibiotickou léčbu komunitních respiračních infekcí v primární péči. Prakt. Lek 2003; 83: 502-515. Ke staľení na: http://www.cls.cz/dalsi-odborne-projekty.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.